FDA Drug Application (202230) for LOSARTAN POTASSIUM by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number202230
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOSARTAN POTASSIUM
Active IngredientLOSARTAN POTASSIUM

Active IngredientCount
List of drugs with Active Ingredient LOSARTAN POTASSIUM4


Back to FDA Applications sponsored by MACLEODS PHARMS LTD